The stock has demonstrated a strong overall uptrend over the past six months, with the price rising from approximately $35.20 in early October 2025 to $62.64 by March 31, 2026, representing a gain of over 77%. This bullish momentum has been particularly pronounced in recent months. Over the last one-month and three-month periods, the stock has surged 46.8% and 78.3%, respectively, significantly outperforming the broader market as indicated by positive relative strength figures of 52.1 and 82.9. The current price of $62.64 is near the upper end of its 52-week range of $12.04 to $66.75, trading just 6.2% below the yearly high, which suggests the stock is in a technically strong position.

Revenue and profitability have shown volatility on a quarterly basis. Q4 2025 revenue of $1.81 billion was down 1.0% year-over-year, but net income improved significantly to $77.7 million from a loss of $55.7 million in Q4 2024. The gross margin for Q4 2025 was 21.0%, a substantial recovery from 6.5% a year prior. The company's financial health appears stable, with a current ratio of 1.60 and a debt-to-equity ratio of 0.92, indicating manageable leverage. Operating cash flow for Q4 2025 was a robust $200.2 million, and trailing twelve-month free cash flow stands at $323.2 million, providing solid liquidity. Operational efficiency metrics are positive, with a return on equity (ROE) of 24.4% and a return on assets (ROA) of 8.4%, reflecting effective use of capital.